Atlas Trials

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

Clinical trial NCT04329572 · SUSPENDED

Trial details

NCT number
NCT04329572
Sponsor
Azidus Brasil
Status
SUSPENDED
Phase
Early Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2020-04-23
Primary completion
2020-05-31
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.